A New York Times story this week about tennis legend Chris Evert’s battle—twice—with ovarian cancer painted a simple and powerful picture: Fearing for her own risk after her sister died of the disease, Evert got tested, caught it early, as stage 1, and treated it successfully in 2022. And though it returned—stage 1 again, meaning it had not spread—she was able to catch that, too, and treat it again. Now the 69-year-old has been declared cancer-free a second time.
“As with her original diagnosis,” the story notes, “early testing was critical—a message Ms. Evert shares zealously.”
